Abstract
PURPOSE To assess the use of in vivo proton MR spectroscopy for characterization of intracranial mass lesions and to ascertain its reliability in grading of gliomas.
METHODS One hundred twenty patients with intracranial masses were subjected to volume selective spectroscopy using stimulated echo acquisition mode (echo time, 20 and 270 milliseconds) and spin echo (echo time, 135 milliseconds) sequences. The intracranial lesions were grouped into intraaxial and extraaxial, as judged with MR imaging. Assignment of resonances was confirmed in two samples each of brain abscess, epidermoid cyst, and tuberculoma using ex vivo high-resolution MR spectroscopy.
RESULTS The in vivo spectra appeared distinct compared with normal brain in all the cases. All high-grade gliomas (n = 37) showed high choline and low or absent N-acetyl-L-aspartate and creatine along with lipid and/or lactate, whereas low-grade gliomas (n = 23) were characterized by low N-acetyl-aspartate and creatine and high choline and presence of only lactate. N-acetyl-aspartate/choline ratio was significantly lower and choline/creatine ratio was significantly higher in high-grade gliomas than in low-grade gliomas. Presence of lipids suggested a higher grade of malignancy. All metastases (n = 7) showed lipid and lactate, whereas choline was visible in only four cases. Epidermoids showed resonances from lactate and an unassigned resonance at 1.8 ppm. Meningiomas could be differentiated from schwannomas by the presence of alanine in the former. Among the infective masses, pyogenic abscesses (n = 6) showed resonances only from cytosolic amino acids, lactate, alanine, and acetate; and tuberculomas (n = 11) showed only lipid resonances.
CONCLUSIONS In vivo proton MR spectroscopy, helps in tissue characterization of intracranial mass lesions. Spectroscopy is a reliable technique for grading of gliomas when N-acetyl-aspartate/choline and choline/creatine ratios and presence of lipids are used in combination.
- Copyright © American Society of Neuroradiology
In this issue
Jump to section
Related Articles
Cited By...
- Deletion of Crtc1 leads to hippocampal neuroenergetic impairments associated with depressive-like behavior
- Imaging in children presenting with acute neurological deficit: paediatric stroke mimics
- Oncologic PET/MRI, Part 1: Tumors of the Brain, Head and Neck, Chest, Abdomen, and Pelvis
- Imaging hypoxia in gliomas
- Proton MR Spectroscopy in a 1T Open MR Imaging System
- Noninvasive Magnetic Resonance Spectroscopic Imaging Biomarkers to Predict the Clinical Grade of Pediatric Brain Tumors
- Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis
- Differentiation of Tuberculous from Pyogenic Brain Abscesses with In Vivo Proton MR Spectroscopy and Magnetization Transfer MR Imaging
- MR Imaging and Single-Photon Emission CT Findings after Gene Therapy for Human Glioblastoma
- MR Spectroscopy in Gliomatosis Cerebri
- Effect of Voxel Position on Single-Voxel MR Spectroscopy Findings
- BRAIN IMAGING
- Proton MR Spectroscopy and Preoperative Diagnostic Accuracy: An Evaluation of Intracranial Mass Lesions Characterized by Stereotactic Biopsy Findings
- Use of Diffusion-Weighted MR Imaging in Differential Diagnosis Between Intracerebral Necrotic Tumors and Cerebral Abscesses
- Transient MRI enhancement in a patient with seizures and previously resected glioma: Use of MRS
- In Vivo Proton MR Spectroscopy of Untreated and Treated Brain Abscesses
- Magnetization Transfer MR Imaging in CNS
- Classification of Biopsy-Confirmed Brain Tumors Using Single-Voxel MR Spectroscopy